Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center

About this trial

The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic.

In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease.

Disqualifiers

None

Trial population

Participants seen at MD Anderson Cancer Center with diagnosed or suspectied endocrine disease.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Data Collection

    Other intervention

    Participant information collected from either source document or direct participant response.

  • Follow Up

    Behavioral

    Participants followed up at the return to clinic visits. If participant cannot come to clinic, either a questionnaire mailed requesting follow-up, or participant called. Participants followed for a length of 15 years at intervals of every 2-3 years.

Treatment groups

15,000 Participants
are divided into 1 treatment group
Group A: Endocrine Disease Group2 interventions

Trial outcomes

Primary outcomes

1

Research Database Compilation from Suspected or Diagnosed Endocrine Disease Participants by Medical Record Review and Follow Up

Database compiled from continuous collection of data on patients diagnosed with surgical endocrine disease or patients who are at risk for developing endocrine neoplasia and/or disease, and by prospective follow-ups of patient populations.

Time frame
15 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.